Interleukin-1 (IL-1) mediates many components of generalized host response to injury and may also contribute to local vascular pathology during immune or inflammatory responses. Because altered function of smooth muscle cells (SMC) accompanies certain vascular diseases, we tested whether SMC themselves might produce this hormone. Unstimulated SMC contain little or no IL-i mRNA. However, exposure to bacterial endotoxin caused accumulation of IL-1 mRNA in SMC cultured from human vessels. Endotoxin maximally increased IL-ift mRNA in SMC after 4-6 h. The lowest effective concentration of endotoxin was 10 pg/ml. 10 ng/ml produced maximal increases in IL-iS mRNA. Interleukin-la mRNA was detected when SMC were incubated with endotoxin under "superinduction" conditions with cycloheximide. Endotoxin-stimulated SMC also released biologically functional IL-1, measured as thymocyte costimulation activity inhibitable by anti-IL-i antibody. Thus, human SMC can express IL-ift and IL-ia genes, or very similar ones, and secrete biologically active product in response to a pathological stimulus. Endogenous local production of this inflammatory mediator by the blood vessel wall's major cell type could play an important early role in the pathogenesis of vasculitis and arteriosclerosis.
Introduction
It is increasingly apparent that the blood vessel is not a passive conduit, but a complex organ composed ofhighly differentiated cells with specialized functions that play important roles in health and disease. The endothelial cell that lines the luminal surface of the vessel wall has recently received much attention in this regard. Blood-borne signals can modulate several important vascular endothelial cell functions related to thrombosis, interaction with leukocytes, and immune competence (1-7). Endothelial cells can also secrete substances that influence the contractile or growth properties of smooth muscle cells (SMC)' that A preliminary report of this work was presented as an abstract in 1986. (Clin. Res. 34:32 IA).
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comprise the tunica media of the vessel (8) (9) (10) . Although the vascular SMC is by far the most numerous cell type in the vessel wall, its repertoire of inducible responses has received very little attention. The SMC is generally regarded as a target for secretory products of endothelial cells, platelets, and leukocytes, rather than as a source of signals that control the function of other cell types (10) .
There is some evidence that SMCs themselves may elaborate mediators involved in the pathogenesis of vascular diseases.
Inbred mice of the MRL/lpr strain develop a spontaneous autoimmune vasculitis. In contrast to vascular SMCs from normal mice, those from arteries of MRL/lpr mice express I-regionassociated (Ia) antigens and release an interleukin 1-like thymocyte activating activity (1 1) . These altered immune functions ofvascular SMCs probably contribute to the localized pathology in these mice with genetically determined vasculitis.
Interleukin 1 (IL-1), formerly thought to be produced primarily by cells of the monocyte/macrophage lineage, mediates several key components of systemic acute phase response (12) (13) (14) . Certain biological properties of IL-l, such as its abilities to act as a chemoattractant and degranulating agent and to induce synthesis ofseveral proteins, including collagen and proteinases, support the concept that IL-l is also involved in the development of local lesions associated with tissue injury (e.g., synovitis, hepatic or pulmonary fibrosis). In the context of the blood vessel, IL-I can induce several pathogenic functions of vascular endothelial cells, such as synthesis of a tissue-factor-like procoagulant activity and increased leukocyte adhesion (2) (3) (4) (17) . These cells were main-chased from the American Type Culture Collection, Rockville, MD, and was maintained and passaged as recommended.
Sources, preparation, and labeling of DNA probes. There are two known human genes that encode molecules with IL-I activity. The products of these genes share only 26% homology of amino acid sequence and have distinct isoelectric points (p1; 18, 19) . IL-1,6 has a pI of 7 and is the major form expressed by human monocytes (12, 18) . IL-la has a pI of 5 and is the less abundant species of IL-l mRNA in activated human mononuclear phagocytes (19) . The IL-I#l probe used in these studies was an Aha III-to-Fnud II fragment (1.1 kilobases [kb]) ofa fulllength cDNA clone (pCD-418) that encodes the precursor for this form (18). For the alpha species of human IL-1 (p1, 5) we used a synthetic oligonucleotide probe (positions 298-339) that was end-labeled with gamma [32P]dATP to specific activities >109 dpm/1g DNA (19, 20) .
The #l-tubulin probe used was a Pst 1-to-Bam HI fragment (1.3 kb) of a rat #l-tubulin cDNA clone (RBT.3) that is expressed constitutively in many tissues (21) . This fragment contains most ofthe translated region of this clone and is highly conserved between species. Plasmids were isolated chromatographically (22 (20) .
Extraction ofRNA and Northern analysis. Total cellular RNA was isolated by the guandinium isothiocyanate/cesium chloride method (20) . The concentration of RNA was determined by absorbance at 260 nm. The ratios of 28 S: 18 S RNA and of A 260/A 280 were greater than 2: 1. For Northern hybridization analysis, RNA was electrophoresed into agarose gels (1.2%) that contained formaldehyde (2.2 M). After capillary transfer to nylon membranes (Hybond-N, Amersham Corp., Arlington Heights, IL), the nucleic acids were immobilized by short-wave UV irradiation. We used standard techniques for prehybridization, hybridization, and autoradiography (20) . Hind III fragments of phage lambda DNA were used as size markers. Quantitative analysis ofautoradiograms from Northern blots required use ofa soft laser densitometer (Ultroscan 2202; LKB Instruments, Gaithersburg, MD) equipped with a recording integrator (HP 3390A). The results presented represent arbitrary units that correspond to the relative areas under the densitometric peaks.
Biological determination ofinterleukin-J activity. Biologically functional IL-I was measured as the ability to increase the proliferation of thymocytes incubated with a suboptimal concentration ofthe mitogenic lectin phytohemagglutinin (PHA). The ability to complement PHA-induced mitogenesis is known as thymocyte costimulation, and is characteristic of IL-I (23, 24) . Thymocytes from C3H/HeJ mice (Jackson Laboratory, Bar Harbor, ME) were incubated for 72 h in RPMI 1640 medium supplemented with fetal calfserum (10%), PHA (I ug/ml), with or without test specimens. Tritiated thymidine (6-7 Ci/mM, 10 ,Ci/ml) was added during the last 18 h of this incubation, and the radioactivity incorporated was determined by liquid scintillation spectroscopy. Interleukin-l f produced by recombinant DNA techniques or purified from human blood monocytes was used as a positive control. Triplicate determinations were performed on each sample, and results are presented as mean±standard deviation.
Results
Human vascular SMCs express the IL-]# gene in response to bacterial endotoxin. Human vascular SMCs cultured under the usual conditions contained little or no messenger RNA (mRNA) that hybridized with the IL-1,I probe ( Fig. 1) . Endotoxins obtained from Gram-negative bacteria are potent inducers of IL-1 production by mononuclear phagocytes (12) (13) (14) . Accordingly, we tested whether this pathologic stimulus would induce expresSion of the IL-1 ( (Fig. 2) . In two independent experiments, IL-I# mRNA levels after 24 h of continuous exposure to endotoxin were lower than those measured after 4 or 6 h ( Fig. 2 and data not shown) . The continuous presence of endotoxin was not required for IL1 induction in these cells. 30 min of exposure to endotoxin (1 Ag/ml), followed by washing and subsequent incubation without endotoxin, produced a similar increase in IL,1I# mRNA levels 4 h after initial exposure, as did incubation for the entire 4-h period in the continued presence of endotoxin (Fig. 3) .
The increased expression of the IL-Il3 gene in SMCs also depended on the concentration ofendotoxin. Concentrations as low as 10 pg/ml increased IL-fl mRNA levels severalfold (Fig.  4) . Polymyxin B, an antagonist of the actions of endotoxin mediated by the lipid A moiety, inhibited this response (Fig. 4) . This result confirmed that the ability ofendotoxin preparations Mg/ml) for the times indicated. RNA was extracted and Northern blotting was performed (see Fig. 1 ). The two left lanes contain RNA extracted from U-937 cells (see Fig. 1 (Fig. 6 and data not shown) . In SMCs incubated with cycloheximide (10 gg/ml), IL-ljI mRNA increased and IL-la mRNA was detected (Fig. 6 ). Simultaneous incubation with cycloheximide and endotoxin increased mRNA for both ofthese human IL-I genes substantially (Fig. 6) (Tables I and II, Fig.  7 ). Medium collected from endotoxin-stimulated SMCs secreted biological activity that was detected over a range of concentrations tested (Table I) . Thymocyte costimulation activity released by stimulated saphenous vein SMCs was partially neutralized by rabbit antihuman monocyte IL-I antibody diluted 1:100 (Fig.  7, solid bars) . The same dilution of nonimmune serum did not reduce this activity (Fig. 7, crosshatched bars) . In an independent experiment, human aortic SMCs treated with endotoxin released thymocyte costimulation activity that was completely neutralized by the anti-IL-antibody (Table II) .
Discussion
The vascular SMC is an unexpected and novel source of IL-1, an important inflammatory mediator previously thought to be produced primarily by mononuclear phagocytes. Recently, pro- duction of IL-I-like activity has been attributed to other cells that are not derived from bone marrow (3, (25) (26) (27) (28) (29) (30) . For example, human keratinocytes can produce a thymocyte-activating factor that resembles IL-1 (25) . Astrocytes and oligodendroglia are another potential source of such activity (26). In addition, several laboratories have observed IL-I-like activity secreted by B lymphocytes, epithelial and mesangial cells, and vascular endothelial cells (3, 7, (27) (28) (29) (30) . We are unaware of previous descriptions of such activity from human vascular SMCs. 10 ,ug/ml) for 24 h. t IL-I purified as previously described (24) . Data are thymidine incorporation in cpm (mean±SD, n = 3). The background incorporation induced by PHA alone in this experiment was 4,021±677. * Rabbit anti-monocyte-derived IL-I antibody was added at 1: 100 dilution.
f Endotoxin exposure was to E. coli 055:B5 (10 ,ug/ml) for 24 h.
Incubation of SMCs with cycloheximide increased the levels of IL-lIa and IL-1# mRNA, and accentuated the endotoxininduced increases in these transcripts (Fig. 6 ). This phenomenon, known as "superinduction," may be due to increased transcription and/or reduced rate of mRNA catabolism (31, 32) . activated human blood monocytes contain at least 50-fold more mRNA for IL-1I8 than for IL-la (33) . The lower steady-state levels of IL-la relative to IL-IfB mRNA detected in the SMCs might also be due to differences in the stability of the specific messages, the efficiency ofdetection with probes, or hybridization conditions employed. However, the specific activity of the endlabeled IL-la probe was actually substantially higher than that of the nick-translated IL-lB cDNA probe (see Methods) , and the end-labeled probe readily detected IL-1 a sequences in RNA isolated from human mononuclear cells exposed to endotoxin without cycloheximide (data not shown).
The RNA species isolated from SMCs that hybridized with the IL-1 DNA probes used in this study had (Fig. 7) . However, our data do not exclude that a product of a heretofore undescribed IL-I gene or genes, or that a tissue-specific mRNA produced by exon shuffling, could contribute to the biological activity released by the SMCs.
Our finding that vascular SMCs express IL-1 genes in response to a pathological stimulus has several important implications. Examples ofcommunication between different types of cell in the blood vessel wall are increasing rapidly. IL-I has profound effects on a number of important functions of vascular endothelial cells. Under normal conditions vascular endothelial cells provide the ideal nonthrombogenic lining for blood vessels (34) . When exposed to IL-1, however, these cells express a tissue factor-like procoagulant activity on their surface and could thus actually promote local thrombosis at sites of IL-I release (2, 3, 34) . IL-I increases the adhesiveness of endothelial cells for leukocytes of all classes tested, including granulocytes and monocytes (4). Exposure to this cytokine also causes a striking shape change of human endothelial cells in culture, probably due to reorganization of the cytoskeleton (35). IL-I alters the pattern of prostanoid synthesis by endothelial cells (36, 37) . These and other activities of IL-l on endothelial cells have already been confirmed using recombinant IL-la and IL-1# (38, 39) .
Because of these manifold effects of IL-I on endothelial function, the production and secretion of this mediator by the underlying SMCs might provide a novel example of interaction between neighboring cell types in the vascular wall. Information transfer between adjacent cells of different types has been termed "paracrine" control (40) . There are already a number ofexamples of potential paracrine regulation of SMCs by products of endothelial cells (8) (9) (10) . The present data suggest that information may also flow in the opposite direction, from SMCs to the endothelium.
Studies on the MRL/lpr mouse provide an example of how IL-I production by SMCs might be involved in vascular disease. These mice develop a spontaneous autoimmune arteritis, characterized by infiltration of mononuclear cells, followed by cytolytic injury to arterial SMCs. Moyer and Reinisch found that SMCs isolated from the media of these mice expressed Class II major histocompatibility complex determinants (Ia molecules), and thus might function as antigen-presenting cells. In addition, they found that SMCs cultured from arteries of MRL/lpr mice, but not from congenic C3H mice, secreted IL-I-like biological activity (1 1). These studies on vasculitic mice support the potential in vivo relevance ofthe present observations on cultured human vascular SMCs ( 1).
Since the characteristic biological activities of IL-I include chemotaxis and activation of granulocytes and T-cells, local production of IL-I is likely involved in the pathogenesis of vascular inflammation in other situations. By increasing the expression of leukocyte adherence molecules on the surface of neighboring endothelial-cells, IL-I secreted by SMC could recruit leukocytes to sites of vascular injury or inflammation (4, 5 
